Explore the Potential with AI-Driven Innovation
The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.
Our selection of compounds is from a large virtual library of over 60 billion molecules. The production and distribution of these compounds are managed by our partner Reaxense.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We use our state-of-the-art dedicated workflow for designing focused libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our strategy employs molecular simulations to explore an extensive range of proteins, capturing their dynamics both individually and within complexes with other proteins. Through ensemble virtual screening, we address proteins' conformational mobility, uncovering key binding sites at both functional regions and remote allosteric locations. This comprehensive investigation ensures a thorough assessment of all potential mechanisms of action, with the goal of discovering innovative therapeutic targets and lead molecules across across diverse biological functions.
Several key aspects differentiate our library:
partner
Reaxense
upacc
Q68J44
UPID:
DUS29_HUMAN
Alternative names:
Dual specificity phosphatase 27; Dual specificity phosphatase DUPD1
Alternative UPACC:
Q68J44; B2RP93
Background:
Dual specificity phosphatase 29 (DUSP29), also known as Dual specificity phosphatase 27 and DUPD1, plays a pivotal role in dephosphorylating phosphotyrosine, phosphoserine, and phosphothreonine residues. It exhibits a preference for phosphotyrosine substrates, significantly impacting intracellular signaling cascades. DUSP29 is crucial in skeletal muscle, where it regulates systemic glucose homeostasis through the activation of AMPK, an energy sensor protein kinase, and influences MAP kinase signaling, promoting muscle cell differentiation, development, and atrophy.
Therapeutic significance:
Understanding the role of Dual specificity phosphatase 29 could open doors to potential therapeutic strategies.